As shown in Fig. 5a, decreased HNF3γ expression was observed in EpCAM+ or CD133+ HCC cells compared with EpCAM− or CD133− cells, suggesting that HNF3γ expression was further reduced in liver CSCs. This evidence concerns the gene FOXA3 and hepatocellular carcinoma.